Latest & greatest articles for dementia

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on dementia or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on dementia and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for dementia

421. A systematic review of the effects of physical activity on physical functioning, quality of life and depression in older people with dementia

A systematic review of the effects of physical activity on physical functioning, quality of life and depression in older people with dementia Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

422. The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies

The association of antihypertensive medication use with risk of cognitive decline and dementia: a meta-analysis of longitudinal studies Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

423. Review: in people with dementia, cholinesterase inhibitors may increase syncope and memantine may reduce fractures

Review: in people with dementia, cholinesterase inhibitors may increase syncope and memantine may reduce fractures Review: in people with dementia, cholinesterase inhibitors may increase syncope and memantine may reduce fractures | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username (...) and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here Review: in people with dementia, cholinesterase inhibitors may increase syncope and memantine may reduce fractures Article Text Therapeutics Review: in people

2011 Evidence-Based Mental Health

424. Non-Pharmacological Interventions for Behavioral Symptoms of Dementia

Non-Pharmacological Interventions for Behavioral Symptoms of Dementia Management Briefs Enter search terms Button to search HSRD ® Inside VA Budget and Performance Inside the News Room National Observances Special Events » » » » » Management Briefs Health Services Research & Development Management Briefs Management eBriefs: Provide VA senior managers with results from VA Health Services Research in a concise and timely manner. , April 2019, Issue 152 , March 2019, Issue 151 , March 2019, Issue

2011 Veterans Affairs - R&D

425. Caregiver support groups in patients with dementia: a meta-analysis

Caregiver support groups in patients with dementia: a meta-analysis Untitled Document The CRD Databases will not be available from 08:00 BST on Friday 4th October until 08:00 BST on Monday 7th October for essential maintenance. We apologise for any inconvenience.

2011 DARE.

426. Cross-sectional study: The organisational culture of nursing staff providing long-term dementia care is related to quality of care Full Text available with Trip Pro

Cross-sectional study: The organisational culture of nursing staff providing long-term dementia care is related to quality of care The organisational culture of nursing staff providing long-term dementia care is related to quality of care | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your (...) username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here The organisational culture of nursing staff providing long-term dementia care is related to quality of care Article Text Nursing Issues Cross-sectional

2011 Evidence-Based Nursing

427. Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia: a literature review of evidence Full Text available with Trip Pro

Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia: a literature review of evidence Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia: a literature review of evidence Efficacy and tolerability of antidepressants in the treatment of behavioral and psychological symptoms of dementia: a literature review of evidence Henry G, Williamson D, Tampi RR CRD summary The review (...) found that antidepressants can be an effective treatment for behavioural and psychological symptoms of dementia in elderly demented patients and were usually well tolerated. Limitations in the review, which included failure to assess study quality, differences between the studies and a lack of predefined outcome measures in the review, mean that the authors’ conclusions require cautious interpretation. Authors' objectives To evaluate the efficacy and tolerability of antidepressants for treating

2011 DARE.

428. Survey: Most hospices and palliative care programmes in the USA serve people with dementia; lack of awareness, need for respite care and reimbursement policies are the main barriers to providing this care

Survey: Most hospices and palliative care programmes in the USA serve people with dementia; lack of awareness, need for respite care and reimbursement policies are the main barriers to providing this care Most hospices and palliative care programmes in the USA serve people with dementia; lack of awareness, need for respite care and reimbursement policies are the main barriers to providing this care | Evidence-Based Nursing We use cookies to improve our service and to tailor our content (...) are here Most hospices and palliative care programmes in the USA serve people with dementia; lack of awareness, need for respite care and reimbursement policies are the main barriers to providing this care Article Text Care of the older person Survey Most hospices and palliative care programmes in the USA serve people with dementia; lack of awareness, need for respite care and reimbursement policies are the main barriers to providing this care Tony Ryan 1 , Christine Ingleton 1 Statistics from

2011 Evidence-Based Nursing

429. Randomised controlled trial: Home-based biobehavioural intervention reduces dependence, increases engagement of patients with dementia in the short term and improves care giver well-being and confidence

Randomised controlled trial: Home-based biobehavioural intervention reduces dependence, increases engagement of patients with dementia in the short term and improves care giver well-being and confidence Home-based biobehavioural intervention reduces dependence, increases engagement of patients with dementia in the short term and improves care giver well-being and confidence | Evidence-Based Nursing We use cookies to improve our service and to tailor our content and advertising to you. You can (...) biobehavioural intervention reduces dependence, increases engagement of patients with dementia in the short term and improves care giver well-being and confidence Article Text Care of the older person Randomised controlled trial Home-based biobehavioural intervention reduces dependence, increases engagement of patients with dementia in the short term and improves care giver well-being and confidence Debra J Hain Statistics from Altmetric.com Commentary on: Gitlin LN , Winter L , Dennis MP , et al

2011 Evidence-Based Nursing

430. Non-pharmacological Interventions for Behavioral Symptoms of Dementia

Non-pharmacological Interventions for Behavioral Symptoms of Dementia Evidence-based Synthesis Program Department of Veterans Affairs Health Services Research & Development Service Investigators: Principal Investigator: Maya E. O’Neil, PhD Co-Investigators: Michele Freeman, MPH Vivian Christensen, PhD Robin Telerant, MD Ashlee Addleman, MPH Devan Kansagara, MD, MCR Prepared for: Department of Veterans Affairs Veterans Health Administration Health Services Research & Development Service (...) Washington, DC 20420 Prepared by: Evidence-based Synthesis Program (ESP) Center Portland VA Medical Center Portland, OR Devan Kansagara, MD, MCR, Director A Systematic Evidence Review of Non-pharmacological Interventions for Behavioral Symptoms of Dementia March 2011i Non-pharmacological Interventions for Behavioral Symptoms of Dementia Evidence-based Synthesis Program This report is based on research conducted by the Evidence-based Synthesis Pro- gram (ESP) Center located at the Portland VA Medical

2011 Veterans Affairs Evidence-based Synthesis Program Reports

431. Lower plasma ?-amyloid levels are associated with moderately greater rate of cognitive decline among older people without dementia

Lower plasma ?-amyloid levels are associated with moderately greater rate of cognitive decline among older people without dementia Lower plasma β-amyloid levels are associated with moderately greater rate of cognitive decline among older people without dementia | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see (...) dementia Article Text Aetiology Lower plasma β-amyloid levels are associated with moderately greater rate of cognitive decline among older people without dementia Statistics from Altmetric.com Question Question Are plasma β-amyloid (Aβ) levels associated with cognitive decline among older people without dementia? People Before exclusions, 3075 community-dwelling adults aged 70–79 years were recruited to the Health Aging and Body Composition (Health ABC study) in 1997–1998. They were selected from

2011 Evidence-Based Mental Health

432. Veterans with post-traumatic stress disorder are at increased risk of developing dementia

Veterans with post-traumatic stress disorder are at increased risk of developing dementia Veterans with post-traumatic stress disorder are at increased risk of developing dementiaCommentary | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) of developing dementia Commentary Statistics from Altmetric.com Question Question Is post-traumatic stress disorder (PTSD) associated with the risk of developing dementia among older US veterans? Population 181 093 veterans who were 55 years or older (average age 68.8 years; 96.5% male) treated at a Veterans Affairs (VA) healthcare facility during the baseline period (1997–2000) who did not have dementia. Participants were identified using the VA National Patient Care Database. Participants had to have

2011 Evidence-Based Mental Health

433. A quarter of people with Parkinson's disease without dementia have mild cognitive impairment

A quarter of people with Parkinson's disease without dementia have mild cognitive impairment A quarter of people with Parkinson's disease without dementia have mild cognitive impairment | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal accounts (...) OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here A quarter of people with Parkinson's disease without dementia have mild cognitive impairment Article Text Prevalence A quarter of people with Parkinson's disease without dementia have mild cognitive

2011 Evidence-Based Mental Health

434. White matter hyperintensities are associated with an increased risk of stroke, dementia and mortality

White matter hyperintensities are associated with an increased risk of stroke, dementia and mortality White matter hyperintensities are associated with an increased risk of stroke, dementia and mortality | Evidence-Based Mental Health We use cookies to improve our service and to tailor our content and advertising to you. You can manage your cookie settings via your browser at any time. To learn more about how we use cookies, please see our . Log in using your username and password For personal (...) accounts OR managers of institutional accounts Username * Password * your user name or password? Search for this keyword Search for this keyword Main menu Log in using your username and password For personal accounts OR managers of institutional accounts Username * Password * your user name or password? You are here White matter hyperintensities are associated with an increased risk of stroke, dementia and mortality Article Text Aetiology White matter hyperintensities are associated with an increased

2011 Evidence-Based Mental Health

435. Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Full Text available with Trip Pro

Sertraline or mirtazapine for depression in dementia (HTA-SADD): a randomised, multicentre, double-blind, placebo-controlled trial. Depression is common in dementia but the evidence base for appropriate drug treatment is sparse and equivocal. We aimed to assess efficacy and safety of two of the most commonly prescribed drugs, sertraline and mirtazapine, compared with placebo.We undertook the parallel-group, double-blind, placebo-controlled, Health Technology Assessment Study of the Use (...) of Antidepressants for Depression in Dementia (HTA-SADD) trial in participants from old-age psychiatry services in nine centres in England. Participants were eligible if they had probable or possible Alzheimer's disease, depression (lasting ≥4 weeks), and a Cornell scale for depression in dementia (CSDD) score of 8 or more. Participants were ineligible if they were clinically critical (eg, suicide risk), contraindicated to study drugs, on antidepressants, in another trial, or had no carer. The clinical trials

2011 Lancet Controlled trial quality: predicted high

436. Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. Full Text available with Trip Pro

Efficacy of treating pain to reduce behavioural disturbances in residents of nursing homes with dementia: cluster randomised clinical trial. To determine whether a systematic approach to the treatment of pain can reduce agitation in people with moderate to severe dementia living in nursing homes.Cluster randomised controlled trial.60 clusters (single independent nursing home units) in 18 nursing homes within five municipalities of western Norway.352 residents with moderate to severe dementia (...) group received usual treatment and care.Primary outcome measure was agitation (scores on Cohen-Mansfield agitation inventory). Secondary outcome measures were aggression (scores on neuropsychiatric inventory-nursing home version), pain (scores on mobilisation-observation-behaviour-intensity-dementia-2), activities of daily living, and cognition (mini-mental state examination).Agitation was significantly reduced in the intervention group compared with control group after eight weeks (repeated

2011 BMJ Controlled trial quality: predicted high

437. Memantine for patients with Parkinson`s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial (Abstract)

Memantine for patients with Parkinson`s disease dementia or dementia with Lewy bodies: a randomised, double-blind, placebo-controlled trial Previous studies have suggested that patients with Lewy-body-related dementias might benefit from treatment with the N-methyl D-aspartate receptor antagonist memantine, but further data are needed. Therefore, the efficacy and safety of memantine were investigated in patients with mild to moderate Parkinson's disease dementia (PDD) or dementia with Lewy (...) of the cognitive test scores, ADCS-activities of daily living, and Zarit caregiver burden scores, there were no significant differences between the two treatment groups in any of the study populations. The incidence of adverse events and number of discontinuations due to adverse events were similar in the two groups. The most common serious adverse events were stroke (n=3 in memantine group), falls (n=2 in memantine group; n=1 in placebo group), and worsening of dementia (n=2 in memantine group).Memantine

2010 EvidenceUpdates Controlled trial quality: predicted high

438. Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. Full Text available with Trip Pro

Prediction of 6-month survival of nursing home residents with advanced dementia using ADEPT vs hospice eligibility guidelines. Estimating life expectancy is challenging in advanced dementia, potentially limiting the use of hospice care in these patients.To prospectively validate and compare the performance of the Advanced Dementia Prognostic Tool (ADEPT) and hospice eligibility guidelines to estimate 6-month survival in nursing home residents with advanced dementia.A prospective cohort study (...) conducted in 21 nursing homes in Boston, Massachusetts, of 606 residents with advanced dementia who were recruited between November 1, 2007, and July 30, 2009. Data were ascertained at baseline to determine the residents' ADEPT score (range, 1.0-32.5; higher scores indicate worse prognosis) and whether they met Medicare hospice eligibility guidelines. Survival was followed up to 6 months.Assessment and comparison of the performance of the ADEPT score and hospice guidelines to predict 6-month survival

2010 JAMA

439. Making decisions for people with dementia who lack capacity: qualitative study of family carers in UK. Full Text available with Trip Pro

Making decisions for people with dementia who lack capacity: qualitative study of family carers in UK. To identify common difficult decisions made by family carers on behalf of people with dementia, and facilitators of and barriers to such decisions, in order to produce information for family carers about overcoming barriers.Qualitative study to delineate decision areas through focus groups and complexity of decision making in individual interviews.Community settings in London.43 family carers (...) of people with dementia in focus groups and 46 carers who had already made such decisions in individual interviews.Family carers identified five core problematic areas of decision making: accessing dementia related health and social services; care homes; legal-financial matters; non-dementia related health care; and making plans for the person with dementia if the carer became too ill to care for them. They highlighted the difficulties in making proxy decisions, especially against active resistance

2010 BMJ

440. Survival of people with clinical diagnosis of dementia in primary care: cohort study. Full Text available with Trip Pro

Survival of people with clinical diagnosis of dementia in primary care: cohort study. To estimate survival after a diagnosis of dementia in primary care, compared with people without dementia, and to determine incidence of dementia.Cohort study using data from The Health Improvement Network (THIN), a primary care database.353 general practices in the United Kingdom providing data to THIN.All adults aged 60 years or over with a first ever code for dementia from 1990 to 2007 (n=22 529); random (...) sample of five participants without dementia for every participant with dementia matched on practice and time period (n=112 645).Median survival by age and sex; mortality rates; incidence of dementia by age, sex, and deprivation.The median survival of people with dementia diagnosed at age 60-69 was 6.7 (interquartile range 3.1-10.8) years, falling to 1.9 (0.7-3.6) years for those diagnosed at age 90 or over. Adjusted mortality rates were highest in the first year after diagnosis (relative risk 3.68

2010 BMJ